{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:41:25Z","timestamp":1792698085507,"version":"4.5.0"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"abstract":"<jats:p>Postoperative arthrofibrosis (PTAF) is a debilitating complication of orthopaedic surgery, causing pain, stiffness, and reduced quality of life. Antifibrotic agents (statins, angiotensin receptor blockers [ARBs], and angiotensin-converting enzyme inhibitors [ACEIs]) have been proposed to mitigate PTAF, yet no systematic review has evaluated all three across major orthopaedic surgeries. This review synthesizes evidence on their use for preventing PTAF after shoulder, knee, and hip surgery. PubMed, Google Scholar, and Scopus were searched for clinical studies evaluating statins, ARBs, or ACEIs for PTAF outcomes with \u226590-day follow-up. Quality was assessed using MINORS and ROBINS-I. Fourteen observational studies met (12 retrospective cohort and 2 case-control) inclusion. Most studies investigated ARBs (12 studies), with fewer studies investigating ACEIs (7) and statins (5). The mean MINORS score was 17.6, and most (10\/14) had serious risk of bias. In total knee arthroplasty (TKA), three studies linked ARBs to reduced manipulation under anesthesia (MUA) or lysis of adhesions, although four found no effect on MUA, range of motion (ROM), or arthrofibrosis. ACEI results were inconsistent, with one study showing modestly reduced MUA but three others no effect; ROM findings were mixed, including one reporting worse outcomes. Statins showed no benefit, and pooled TKA\/total hip arthroplasty data found no drug associations with MUA. In arthroscopic rotator-cuff repairs (ARCRs), ARBs were associated with reduced adhesive capsulitis and improved ROM inconsistently. ACEI use correlated with worse ROM and patient-reported outcomes, while statins again showed no effect. A pooled analysis of arthroscopic shoulder procedures reported no associations between ARBs or ACEIs and PTAF outcomes. Current observational data provide conflicting and insufficient support for using statins, ARBs, or ACEIs to prevent PTAF. While some studies suggest a potential benefit for ARBs in TKA and ARCR, findings are inconsistent. Higher quality studies are needed to better understand their clinical role in preventing PTAF.<\/jats:p>","DOI":"10.5435\/jaaos-d-25-01368","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:00:09Z","timestamp":1792695609000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Systemic Antifibrotic Agents on Patient and Surgical Outcomes After Joint Surgery: A Systematic Review"],"prefix":"10.5435","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0498-6844","authenticated-orcid":false,"given":"Nihal","family":"Nagesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A.","family":"Romero-Padron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L.","family":"Fonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas R.","family":"Kossoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-5409","authenticated-orcid":false,"given":"Joshua S.","family":"Everhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,22]]},"reference":[{"key":"R1-20261022","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41413-019-0047-x","article-title":"Pathological mechanisms and therapeutic outlooks for arthrofibrosis","volume":"7","author":"Usher","year":"2019","journal-title":"Bone Res"},{"key":"R2-20261022","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1302\/0301-620X.98B10.37957","article-title":"International consensus on the definition and classification of fibrosis of the knee joint","volume":"98-B","author":"Kalson","year":"2016","journal-title":"Bone Joint J"},{"key":"R3-20261022","doi-asserted-by":"crossref","first-page":"16469","DOI":"10.1038\/srep16469","article-title":"Fibrosis is a common outcome following total knee arthroplasty","volume":"5","author":"Abdul","year":"2015","journal-title":"Sci Rep"},{"key":"R4-20261022","first-page":"369","article-title":"Arthrofibrosis of the knee following ligament surgery","volume":"52","author":"DeHaven","year":"2003","journal-title":"Instr Course Lect"},{"key":"R5-20261022","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1060-1872(98)80057-9","article-title":"Arthrofibrosis: Etiology, classification, histopathology, and treatment","volume":"6","author":"Gillespie","year":"1998","journal-title":"Oper Tech Sports Med"},{"key":"R6-20261022","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1177\/03635465010290052401","article-title":"Motion loss after ligament injuries to the knee. Part I: Causes","volume":"29","author":"Millett","year":"2001","journal-title":"Am J Sports Med"},{"key":"R7-20261022","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00167-015-3799-x","article-title":"Procedural intervention for arthrofibrosis after ACL reconstruction: Trends over two decades","volume":"25","author":"Sanders","year":"2017","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"R8-20261022","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ocl.2019.02.005","article-title":"Arthrofibrosis after total knee arthroplasty: Pathophysiology, diagnosis, and management","volume":"50","author":"Thompson","year":"2019","journal-title":"Orthop Clin North Am"},{"key":"R9-20261022","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/jor.23419","article-title":"Development of arthrogenic joint contracture as a result of pathological changes in remobilized rat knees","volume":"35","author":"Kaneguchi","year":"2017","journal-title":"J Orthop Res"},{"key":"R10-20261022","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00441-015-2343-0","article-title":"Connective tissue cells expressing fibro\/adipogenic progenitor markers increase under chronic damage: Relevance in fibroblast-myofibroblast differentiation and skeletal muscle fibrosis","volume":"364","author":"Contreras","year":"2016","journal-title":"Cell Tissue Res"},{"key":"R11-20261022","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0002-9440(10)63188-4","article-title":"Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: A key event in muscle fibrogenesis","volume":"164","author":"Li","year":"2004","journal-title":"Am J Pathol"},{"key":"R12-20261022","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jcb.30217","article-title":"The pathophysiology and treatment of musculoskeletal fibrosis","volume":"123","author":"Sheets","year":"2022","journal-title":"J Cell Biochem"},{"key":"R13-20261022","doi-asserted-by":"crossref","first-page":"115644","DOI":"10.1016\/j.bcp.2023.115644","article-title":"Anti-fibrotic effects of statin drugs: A review of evidence and mechanisms","volume":"214","author":"Dolivo","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"R14-20261022","doi-asserted-by":"crossref","first-page":"107245","DOI":"10.1016\/j.phrs.2024.107245","article-title":"The current landscape of antifibrotic therapy across different organs: A systematic approach","volume":"205","author":"Fuster-Martinez","year":"2024","journal-title":"Pharmacol Res"},{"key":"R15-20261022","doi-asserted-by":"crossref","first-page":"e70089","DOI":"10.1002\/jeo2.70089","article-title":"Limited evidence for the usage of renin-angiotensin-aldosterone pathway blockers to prevent arthrofibrosis after total knee arthroplasty. A systematic review of clinical evidence","volume":"11","author":"Anzillotti","year":"2024","journal-title":"J Exp Orthop"},{"key":"R16-20261022","doi-asserted-by":"crossref","first-page":"S1010","DOI":"10.1016\/j.arth.2022.03.026","article-title":"Perioperative use of antifibrotic medications associated with lower rate of manipulation after primary TKA: An analysis of 101,366 patients","volume":"37","author":"Premkumar","year":"2022","journal-title":"J Arthroplasty"},{"key":"R17-20261022","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/CIRCULATIONAHA.104.528695","article-title":"Angiotensin-converting enzyme inhibitors: A new mechanism of action","volume":"112","author":"Peng","year":"2005","journal-title":"Circulation"},{"key":"R18-20261022","doi-asserted-by":"crossref","first-page":"H1796","DOI":"10.1152\/ajpheart.00781.2005","article-title":"Novel mechanism of action of ACE and its inhibitors","volume":"289","author":"Carretero","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R19-20261022","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","article-title":"Methodological index for non-randomized studies (minors): Development and validation of a new instrument","volume":"73","author":"Slim","year":"2003","journal-title":"ANZ J Surg"},{"key":"R20-20261022","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R21-20261022","doi-asserted-by":"crossref","first-page":"e274","DOI":"10.3928\/01477447-20201216-09","article-title":"Angiotensin receptor blockers were not associated with decreased arthrofibrosis after total knee arthroplasty","volume":"44","author":"Hernandez","year":"2021","journal-title":"Orthopedics"},{"key":"R22-20261022","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1007\/s00402-022-04696-8","article-title":"The effect of losartan on range of motion and rates of manipulation in total knee arthroplasty: A retrospective matched cohort study","volume":"143","author":"Arraut","year":"2023","journal-title":"Arch Orthop Trauma Surg"},{"key":"R23-20261022","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.arth.2023.10.015","article-title":"Postoperative angiotensin receptor blocker use is associated with decreased rates of manipulation under anesthesia, arthroscopic lysis of adhesions, and prosthesis-related complications in patients undergoing total knee arthroplasty","volume":"39","author":"Albright","year":"2024","journal-title":"J Arthroplasty"},{"key":"R24-20261022","doi-asserted-by":"crossref","first-page":"103851","DOI":"10.1016\/j.otsr.2024.103851","article-title":"The association between losartan potassium prescription and postoperative outcomes following total knee arthroplasty: A TriNetX analysis","volume":"110","author":"Rana","year":"2024","journal-title":"Orthop Traumatol Surg Res"},{"key":"R25-20261022","first-page":"26","article-title":"ACE inhibitor use does not significantly affect occurrence of manipulation under anesthesia following total knee arthroplasty","volume":"5","author":"Frederick","year":"2024","journal-title":"J Orthop Exp Innov"},{"key":"R26-20261022","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13018-020-1555-5","article-title":"Angiotensin II blockade had no effect on range of motion after total knee arthroplasty: A retrospective review","volume":"15","author":"Langston","year":"2020","journal-title":"J Orthop Surg Res"},{"key":"R27-20261022","doi-asserted-by":"crossref","first-page":"S350","DOI":"10.1016\/j.arth.2023.03.076","article-title":"Nonsteroidal anti-inflammatory drugs and oral corticosteroids mitigated the risk of arthrofibrosis after total knee arthroplasty","volume":"38","author":"Salmons","year":"2023","journal-title":"J Arthroplasty"},{"key":"R28-20261022","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/j.arth.2021.05.022","article-title":"Perioperative statin use may reduce postoperative arrhythmia rates after total joint arthroplasty","volume":"36","author":"Bonano","year":"2021","journal-title":"J Arthroplasty"},{"key":"R29-20261022","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jseint.2025.05.007","article-title":"Postoperative angiotensin II receptor blocker use is associated with reduced 2-year reoperation rates in male patients undergoing arthroscopic rotator cuff repair","volume":"9","author":"Fong","year":"2025","journal-title":"JSES Int"},{"key":"R30-20261022","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1016\/j.arthro.2024.11.084","article-title":"Perioperative losartan is associated with similar rates of additional surgical procedures for postoperative shoulder stiffness after primary arthroscopic rotator cuff repair but lower rates of secondary debridement and repair","volume":"41","author":"Miltenberg","year":"2025","journal-title":"Arthroscopy"},{"key":"R31-20261022","first-page":"101165","article-title":"Angiotensinogen II receptor blockers may decrease risk of adhesive capsulitis after rotator cuff repair","volume":"7","author":"Lee","year":"2025","journal-title":"Arthrosc Sports Med"},{"key":"R32-20261022","doi-asserted-by":"crossref","first-page":"23259671241305089","DOI":"10.1177\/23259671241305089","article-title":"Association of antihypertensive and Statin medication usage with postoperative stiffness after arthroscopic rotator cuff repair: A retrospective cohort study","volume":"13","author":"Perez","year":"2025","journal-title":"Orthopaedic J Sports Med"},{"key":"R33-20261022","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.asmr.2023.05.005","article-title":"Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors have no significant relationship with postoperative arthrofibrosis after shoulder arthroscopy","volume":"5","author":"Bi","year":"2023","journal-title":"Arthrosc Sports Med Rehabil"},{"key":"R34-20261022","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/036354659502300115","article-title":"Prevention of arthrofibrosis after anterior cruciate ligament reconstruction using the central third patellar tendon autograft","volume":"23","author":"Cosgarea","year":"1995","journal-title":"Am J Sports Med"},{"key":"R35-20261022","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/036354659702500610","article-title":"Anterior cruciate ligament reconstruction with autogenous patellar tendon graft followed by accelerated rehabilitation. A two- to nine-year followup","volume":"25","author":"Shelbourne","year":"1997","journal-title":"Am J Sports Med"},{"key":"R36-20261022","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0038-1655741","article-title":"Predictors of knee arthrofibrosis and outcomes after arthroscopic lysis of adhesions following ligamentous reconstruction: A retrospective case-control study with over two years' average Follow-Up","volume":"32","author":"Bodendorfer","year":"2019","journal-title":"J Knee Surg"},{"key":"R37-20261022","doi-asserted-by":"crossref","first-page":"2325967119875415","DOI":"10.1177\/2325967119875415","article-title":"Prospective evaluation of range of motion in acute ACL reconstruction using patellar tendon autograft","volume":"7","author":"Harris","year":"2019","journal-title":"Orthop J Sports Med"},{"key":"R38-20261022","doi-asserted-by":"crossref","first-page":"2325967119829547","DOI":"10.1177\/2325967119829547","article-title":"Factors associated with a delay in achieving full knee extension before anterior cruciate ligament reconstruction","volume":"7","author":"Gage","year":"2019","journal-title":"Orthop J Sports Med"},{"key":"R39-20261022","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/JSA.0000000000000324","article-title":"Arthrofibrosis nightmares: Prevention and management strategies","volume":"30","author":"Lee","year":"2022","journal-title":"Sports Med Arthrosc Rev"},{"key":"R40-20261022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.52628\/90.2.10815","article-title":"Pharmacological prevention of arthrofibrosis: A systematic review","volume":"90","author":"Rubens","year":"2024","journal-title":"Acta Orthop Belg"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:00:15Z","timestamp":1792695615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,22]]},"references-count":40,"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01368","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,22]]},"assertion":[{"value":"2025-10-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}